Gold Prices Looked Past An Inflation Beat, But Broader Outlook Remains Bearish

Gold prices finished the past 24 hours relatively flat as critical competing headlines fought for the attention of the yellow metal. First, all eyes were on January’s US CPI report. Headline inflation clocked in at 6.4% y/y against the 6.2% estimate.

This was also higher than a prediction I made using a lag analysis model. Still, it was within the error region. More importantly, the model sees February CPI at 6.3% y/y. Combined with a stronger-than-anticipated core reading, this is not great news for the Federal Reserve, which is trying to bring inflation down to a medium-term average target of about 2%.

Financial conditions have been easing since the end of last year as markets priced after the tightening cycle and then some (in the form of anticipated rate cuts towards the end of this year). Including today’s CPI report, markets have added about three rate hikes to the 2-year outlook since the day before January’s non-farm payrolls report blowout.

As a result, the 2-year Treasury yield has rallied almost back to highs from November. This is as the US Dollar found some support. Unsurprisingly, this combination has not been working out great for gold.

Despite the unexpectedly sticky CPI report, gold prices were relatively mute. That is likely due to Fedspeak. Philadelphia Fed President Patrick Harker noted on Tuesday that the central bank was zeroing in on where rates could be restrictive enough – a sign that peak rates might be soon around the corner. But, he also added that the Fed might have to do more.

This likely points to a Fed that might keep rates restrictive for longer. Despite what occurred with gold over the past 24 hours, this may continue spelling more trouble for the anti-fiat yellow metal down the road. Later today, the US will release January retail sales. Tangible outcomes could risk adding further downside pressure to XAU/USD.

On the daily chart, gold is trying to extend losses under the 50-day Simple Moving Average (SMA). That offers an increasingly bearish perspective, focusing on the 38.2% Fibonacci retracement level at 1828. In the event of a turn higher, the 20-day SMA could hold as resistance, maintaining the near-term downside focus.

This Post Has 21 Comments

  1. TimothyPat

    mexican pharmaceuticals online: mexican pharma – mexican drugstore online

  2. TimothyPat

    mexico drug stores pharmacies: mexican pharma – mexican pharmaceuticals online

  3. JosephVor

    buy neurontin online uk: neurontin pill – buy generic neurontin

  4. JosephVor

    ventolin uk price: buy Ventolin – ventolin online united states

  5. Arnoldtib

    lasix furosemide: cheap lasix – lasix 100 mg tablet

  6. Edisonunumb

    pillole per erezione immediata: acquisto viagra – viagra naturale in farmacia senza ricetta

  7. Edisonunumb

    le migliori pillole per l’erezione: viagra – pillole per erezione immediata

  8. Edisonunumb

    viagra originale in 24 ore contrassegno: viagra farmacia – kamagra senza ricetta in farmacia

  9. NormanVaf

    farmacias online seguras: Cialis generico – farmacia online barata

  10. NormanVaf

    comprar sildenafilo cinfa 100 mg espaГ±a: viagra precio – viagra precio 2022

  11. Account binance

    Your article helped me a lot, is there any more related content? Thanks!

  12. ecommerce

    Wow, incredible blog layout! How long have you been running a blog for?
    you made running a blog glance easy. The entire look of your site is great, let alone
    the content material! You can see similar here sklep internetowy

Leave a Reply

Contact Us

Disclaimer

Forex, Crypto, Options, and Binary Options have both large potential rewards and large potential risks. Therefore, before investing or trading any of the assets, ensure you are aware of and willing to accept the accompanying risks. Do not trade money you cannot afford to lose.

All Rights Reserved. None of the content of this website can be published elsewhere by any means without the prior consent of the owner(s). Please, check our terms & conditions and privacy policy before continuing to use this website.

This website and its owner(s) are not in any way liable for any incurred loss, whether caused by the information provided on this website or otherwise. The use of this website, including the content and information provided, is the user’s sole liability.